Santhera Launches AGAMREE® (Vamorolone) in Germany as First
AGAMREE® is the only approved medication in the European Union (EU) for treating all patients from age 4 years with ...
Read moreAGAMREE® is the only approved medication in the European Union (EU) for treating all patients from age 4 years with ...
Read moreApproval by the Medicines and Healthcare products Regulatory Agency (MHRA) of AGAMREE® in the United Kingdom follows marketing authorization for ...
Read moreEuropean Commission (EC) grants marketing authorization for AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.